Surgical treatment for MDR TB patients – preliminary results from a Romanian MDR TB centre

C. Saon, M. Orghidan, M. Ciontu, C. Popa, C. Popa (Bucharest, Romania)

Source: Annual Congress 2006 - Infection, trauma and emphysema
Session: Infection, trauma and emphysema
Session type: Thematic Poster Session
Number: 1597
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Saon, M. Orghidan, M. Ciontu, C. Popa, C. Popa (Bucharest, Romania). Surgical treatment for MDR TB patients – preliminary results from a Romanian MDR TB centre. Eur Respir J 2006; 28: Suppl. 50, 1597

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment results for MDR TB patients after surgery
Source: Eur Respir J 2005; 26: Suppl. 49, 654s
Year: 2005

MDR TB treatment in prison
Source: Eur Respir J 2002; 20: Suppl. 38, 614s
Year: 2002

Surgical treatment of multidrug-resistant tuberculosis (MDR TB)
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003

Treatment results in patients with XDR tuberculosis in Ukraine
Source: Eur Respir J 2007; 30: Suppl. 51, 272s
Year: 2007

A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013

Outcomes of individualized treatment for MDR TB in Iran
Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis
Year: 2007


Linezolid in the treatment of patients with MDR TB and XDR TB
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014

Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India.
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Long-term results of treatment with bedaquiline in patients with drug-resistant tuberculosis
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015


The clinical features and treatment of cases with MDR TB of adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


Our experience in multi drug resistant tuberculosis (MDR TB) treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

MDR-TB treatment outcomes in HIV positive patients
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia)
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015

Efficacy of treatment in MDR and XDR lung TB patients in the follow-up period with the use of new anti-tuberculosis agent
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019

Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013